Science Explorer Back to mapMap
Discussion
Researcher · Kagawa University · Japan

Kyuichi Kadota

Kyuichi Kadota publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.

ORCID 0000-0002-6835-453X OpenAlex
World rank
#329,306
of 7,710,434 ranked researchers
Rank in Japan
#2,895
of 383,136
Works
226
Citations
7.5k
Citations per work
33.4
h-index
43
i10-index 87Top 3.7% in Pulmonary and Respiratory Medicine
Kyuichi Kadota

What does Kyuichi Kadota research?

Kyuichi Kadota's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (5%).

Health Sciences: 129 works · 57.1% of their workMedicine: 129 works · 57.1% of their workPulmonary and Respiratory Medicine: 67 works · 29.6% of their workOncology: 39 works · 17.2% of their workSurgery: 23 works · 10.3% of their workEverything else: 58 works · 25.7% of their workLife Sciences: 39 works · 17.2% of their workBiochemistry, Genetics and Molecular Biology: 28 works · 12.3% of their workMolecular Biology: 21 works · 9.3% of their workCancer Research: 7 works · 3.0% of their workImmunology and Microbiology: 11 works · 4.9% of their workImmunology: 11 works · 4.9% of their workTHEIR WORKKyuichi Kadota226works
Life Sciences17%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12957.1%
  2. Everything else5825.7%
    1. Biochemistry, Genetics and Molecular Biology2812.3%
    2. Immunology and Microbiology114.9%
  1. 1Pulmonary and Respiratory Medicine30% of their works
  2. 2Oncology17% of their works
  3. 3Surgery10% of their works
  4. 4Molecular Biology9% of their works
  5. 5Immunology5% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Kyuichi Kadota's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, CT Screening, Lung Cancer, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Chemotherapy632 topics
  2. Clinical Trials562 topics
  3. Targeted Therapy562 topics
  4. Immunotherapy392 topics
  5. CT Screening371 topic
  6. Lung Cancer371 topic
  7. ALK Inhibitors301 topic
  8. EGFR Mutations301 topic
  9. Genomic Profiles261 topic
  10. Small-Cell Lung Cancer261 topic
  11. Epithelial-Mesenchymal Transition222 topics
  12. Activation141 topic
  13. Macrophage141 topic
  14. BAP1 mutations131 topic
  15. Malignant Pleural Mesothelioma131 topic
  16. Fibrosis121 topic
  17. Idiopathic Pulmonary Fibrosis121 topic
  18. Immune Checkpoint Blockade121 topic
  19. PD-1 and PD-L1121 topic
  20. Cancer Stem Cells101 topic
  21. Tumor Metastasis101 topic

Where does Kyuichi Kadota work?

Kyuichi Kadota's main affiliation in the publication record is Kagawa University, Japan.

How many publications and citations does Kyuichi Kadota have?

OpenAlex counts 226 works and 7,538 citations for Kyuichi Kadota, an h-index of 43, ranking #329,306 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kyuichi Kadota. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.